ORZYCOM Trademark

Trademark Overview

On Tuesday, November 7, 2017, a trademark application was filed for ORZYCOM with the United States Patent and Trademark Office. The USPTO has given the ORZYCOM trademark a serial number of 87674362. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 20, 2021. This trademark is owned by JOHNSON & JOHNSON. The ORZYCOM trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of oncologic diseases
orzycom

General Information

Serial Number87674362
Word MarkORZYCOM
Filing DateTuesday, November 7, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 20, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 27, 2018

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of oncologic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, December 20, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 20, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, May 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 6, 2021EXTENSION 5 GRANTED
Monday, April 26, 2021EXTENSION 5 FILED
Thursday, May 6, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 26, 2021TEAS EXTENSION RECEIVED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2020EXTENSION 4 GRANTED
Wednesday, October 28, 2020EXTENSION 4 FILED
Wednesday, October 28, 2020TEAS EXTENSION RECEIVED
Thursday, May 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 12, 2020EXTENSION 3 GRANTED
Tuesday, May 12, 2020EXTENSION 3 FILED
Tuesday, May 12, 2020TEAS EXTENSION RECEIVED
Wednesday, November 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 4, 2019EXTENSION 2 GRANTED
Monday, November 4, 2019EXTENSION 2 FILED
Monday, November 4, 2019TEAS EXTENSION RECEIVED
Wednesday, April 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2019EXTENSION 1 GRANTED
Monday, April 15, 2019EXTENSION 1 FILED
Monday, April 15, 2019TEAS EXTENSION RECEIVED
Tuesday, November 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 4, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, September 10, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, September 10, 2018ASSIGNED TO PETITION STAFF
Monday, August 20, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, April 26, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 17, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 16, 2018ASSIGNED TO EXAMINER
Thursday, November 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 10, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

orzycom oncologic diseases treatment prevention pharmaceutical preparations human